Femcare sold to Utah Medical for £25 million
Mid-market private equity firm Barclays Private Equity has exited Femcare Group, selling its holding in the business to Nasdaq-listed Utah Medical Products for £25 million.
News
Mid-market private equity firm Barclays Private Equity has exited Femcare Group, selling its holding in the business to Nasdaq-listed Utah Medical Products for £25 million.
News
Partner content
Accounting and Finance Software
Accounting and Finance Software